Form 4: Marillyn A. Hewson, Johnson & Johnson Director, Reports Acquisition of Deferred Share Units

Sentiment:

SEC Filing


Director Marillyn A. Hewson reports acquisition of Deferred Share Units (DSUs) related to deferred cash retainer under Johnson & Johnson's director fee plan.

Summary

  • Marillyn A. Hewson, a director of Johnson & Johnson, filed a Form 4 to report changes in beneficial ownership.
  • The report indicates the acquisition of 302.547 Deferred Share Units (DSUs) on September 10, 2024, at a price of $165.94.
  • These DSUs were acquired as part of the Amended and Restated Deferred Fee Plan for Directors, representing deferral of cash retainer.
  • The DSUs will be settled in cash upon termination of Hewson's directorship, with each DSU equivalent to one share of Common Stock at fair market value on the settlement date.
  • Hewson's total holdings include 10,954.9397 DSUs, inclusive of dividend equivalent rights from the Issuer's quarterly dividend.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing, indicating standard compensation practices. The sentiment is neutral to slightly positive as it reflects ongoing director investment in the company.

Positives

  • The acquisition of DSUs reflects Hewson's continued investment and alignment with Johnson & Johnson's long-term performance.
  • The Deferred Fee Plan for Directors allows for tax-efficient compensation and demonstrates a commitment to corporate governance.

Future Outlook

The DSUs will be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's securities, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding director compensation and alignment with company performance.

Key Dates

DateDescription
09/10/2024Date of transaction: Acquisition of Deferred Share Units
09/12/2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.